Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Viking

Adam Thielen Made Financial Sacrifice in Effort to Rejoin Vikings in Trade

Adam Thielen is taking a pay cut to return to the Minnesota Vikings after two seasons with the Carolina Panthers.

Sports Illustrated

Libyan coastguard shot at migrant rescue ship in Mediterranean, NGO claims

The non-profit SOS Mediterranee says the MV Ocean Viking was targeted while carrying 87 rescued migrants to safety.

Euronews

Is Viking’s Growth Still Worth the Premium?

Viking stock dipped after earnings despite strong bookings and raised guidance, as investors focus on slowing pricing growth for 2026

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Viking's Premium Valuation Backed By Strong Growth, Analyst Notes

Viking Holdings Ltd (NYSE:VIK) shares slipped on Wednesday despite the cruise operator posting a strong second-quarter revenue jump and upbeat analyst commentary.

Benzinga

Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug?

Viking Therapeutics Inc. (NASDAQ:VKTX) saw its stock collapse by over 42% on Tuesday after data from its Phase 2 obesity pill trial disappointed investors, sparking a fierce debate between Wall Street bulls and critical biotech experts.

Benzinga

Market Bloodbath: Viking Therapeutics Stock Tanks After Obesity Pill Side Effects Trigger Mass Dropouts

Viking Therapeutics shares plunged 40% after trial data for its obesity pill, VK2735, revealed high dropout rates due to side effects, raising doubts about its competitiveness against rivals Eli Lilly and Novo Nordisk.

International Business Times UK

Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme'

Investors appear disappointed with Viking Therapeutics Inc.’s (NASDAQ:VKTX) data from its Phase 2 trial of an obesity pill.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks

On Tuesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released the much-awaited data from its Phase 2 trial of VK2735 pill, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Benzinga

Top Wall Street Forecasters Revamp Viking Holdings Expectations Ahead Of Q2 Earnings

Viking Holdings Ltd (NYSE:VIK) will release earnings results for the second quarter, before the opening bell on Tuesday, Aug. 19.

Benzinga

Eli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year Bond

Eli Lilly And Co.‘s (NYSE:LLY) recent, and highly unusual, issuance of a 40-year bond is fueling speculation that the pharmaceutical giant may be preparing for a major acquisition, with Viking Therapeutics Inc. (NASDAQ:VKTX) emerging as a potential target.

Benzinga

Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst

Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE-Oral trial to test a daily pill version of VK2735 in obese and overweight adults, a move analysts say could position the company to capitalize on Eli Lilly’s recent setback and…

Benzinga

A first look at Viking Mira, the cruise brand’s new £377m ocean ship

Viking Mira is getting ready to welcome cruise passengers from spring 2026

The Independent UK

2 Growth Stocks Wall Street Predicts Will Soar 74% to 159%

With a strong pipeline, these two biotechs are poised for explosive growth.

Barchart

Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates

Viking Therapeutics Inc (NASDAQ:VKTX) shares are falling in Wednesday’s after-hours session after the company reported financial results for the second quarter.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

9 Appliance Brands That Are No Longer Reliable

When you invest in a new appliance, you expect it to last for years. For decades, consumers trusted certain brand names to deliver durability and performance. However, due to corporate mergers, changes in manufacturing, and a focus on cutting costs, many of those once-great brands are no longer a safe…

Barchart

This Buy-Rated Travel Stock Keeps Cruising to New Highs

Viking Holdings (VIK) shows strong technical momentum and hit a new 52-week high on July 15. The stock has a 100% technical “Buy” signal via Barchart. Shares are up more than 60% in the last year. Fundamentals are robust and analyst sentiment is largely bullish on the cruise and expedition...

The Independent UK

Viking launches new India river cruises

The river cruise brand is working on a new ship that will sail exclusively in the region

Sports Illustrated

Randy Moss Pays Justin Jefferson Big Compliment Regarding Legacy Status

From one Vikings legendary receiver to another.

Get all your
news in one place.

100's of premium titles.
One news app.

Clever Dude

Still American-Made: 5 Appliance Brands Proudly Built in the USA

In a time when so many products are made overseas, it’s refreshing to know some companies are still committed to manufacturing in America. Buying American-made appliance brands not only supports U.S. jobs, but it also often means better quality, easier service, and faster parts replacement. While not every part is…

MarketBeat

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

Evening Standard

Government ‘putting its money where its mouth is’ with £200m for Acorn scheme

Energy Secretary Ed Miliband visited the Acorn site in Aberdeenshire as it was confirmed it would get £200 million of development funding.

Homes & Gardens

The balcony gardens at this year's Chelsea Flower Show showcased a new wave of possibilities for urban spaces – here are the key trends I spotted

What Chelsea Flower Show 2025 balconies tell us - the aesthetic and ecological shifts driving the new garden frontier

MarketBeat

Viking Holdings Posts Strong Q1, Eyes Growth Ahead

After one year of being publicly traded, VIK stock shows resilience and a positive trend, supported by a loyal customer base and an innovative business model

Sports Illustrated

Minnesota Vikings Fans Get Tattooed to Help Announce Team’s 2025 Schedule

The Vikings found a unique, and permanent, way to release their schedule.

The Independent UK

River cruise choice grows as tour operator Trafalgar enters the market

The choice of river cruises continues to grow, with the popular tour operator to launch cruises from next year

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.